تولید مواد اولیه داروئی البرز بالک (سهامی خاص)
دبالک | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/05/19 Fiscal Year 2025/12/2112 Month | 2025/05/25 Fiscal Year 2024/12/2012 Month | 2024/05/05 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 868.17 Billion | 130.294 Billion | 31.978 Billion | |
Trade Receivables | 6.836 Trillion | 3.472 Trillion | 2.407 Trillion | |
Prepayments | 989.147 Billion | 460.726 Billion | 920.894 Billion | |
Raw Materials & Packaging Inventory | 621.673 Billion | 1.834 Trillion | 1.37 Trillion | |
Work-in-Progress Inventory | 52.545 Billion | 45.948 Billion | 19.838 Billion | |
Finished Goods Inventory | 915.211 Billion | 1.35 Trillion | 1.01 Trillion | |
Spare Parts Inventory | 14.584 Billion | 11.95 Billion | 13.459 Billion | |
Goods in Transit | - | 284.546 Billion | 1.409 Trillion | |
Other Inventories | 39.924 Billion | 26.481 Billion | 12.259 Billion | |
Inventories | 1.644 Trillion | 3.553 Trillion | 3.834 Trillion | |
Total Current Assets | 10.337 Trillion | 7.616 Trillion | 7.194 Trillion | |
Long-Term Investments | 116 Million | 114 Million | 109 Million | |
Long-Term Trade Receivables | 11.099 Billion | 7.971 Billion | - | |
Intangible Assets | 8.915 Billion | 14.056 Billion | 15.936 Billion | |
Property, Plant & Equipment | 835.972 Billion | 568.319 Billion | 513.989 Billion | |
Net Fixed Assets | 835.972 Billion | 568.319 Billion | 513.989 Billion | |
Total Non-Current Assets | 856.102 Billion | 590.46 Billion | 530.034 Billion | |
Total Assets | 11.193 Trillion | 8.206 Trillion | 7.724 Trillion | |
Trade Payables | 2.791 Trillion | 698.29 Billion | 1.006 Trillion | |
Advances Received | 4.832 Billion | 26.285 Billion | 12.445 Billion | |
Income Tax Provision | 353.09 Billion | 84.545 Billion | 230.743 Billion | |
Proposed & Payable Dividends | 27.974 Billion | 308.258 Billion | 60.005 Billion | |
Current Borrowings | 1.833 Trillion | 4.861 Trillion | 4.525 Trillion | |
Total Current Liabilities | 5.009 Trillion | 5.979 Trillion | 5.834 Trillion | |
Long-Term Payables | 1.318 Trillion | 17.101 Billion | - | |
Long-Term Borrowings | 828.812 Billion | 793.257 Billion | - | |
Employee Termination Benefits Provision | 85.024 Billion | 54.47 Billion | 35.28 Billion | |
Total Non-Current Liabilities | 2.232 Trillion | 864.828 Billion | 35.28 Billion | |
Total Liabilities | 7.241 Trillion | 6.844 Trillion | 5.869 Trillion | |
Capital | 1.82 Trillion | 920 Billion | 920 Billion | |
Retained Earnings | 1.876 Trillion | 473.962 Billion | 948.196 Billion | |
Legal Reserve | 167.028 Billion | 92 Billion | 92 Billion | |
Share Premium Reserve | 89.632 Billion | -123.531 Billion | -105.14 Billion | |
Total Equity | 3.952 Trillion | 1.362 Trillion | 1.855 Trillion | |
Total Liabilities & Equity | 11.193 Trillion | 8.206 Trillion | 7.724 Trillion | |
Approved Capital | 1.82 Trillion | 920 Billion | 920 Billion | |
Approved Retained Earnings | 1.421 Trillion | 450.303 Billion | 248.996 Billion | |
Approved Legal Reserve | 167.028 Billion | 92 Billion | 92 Billion | |
Total Approved Equity (at AGM) | 3.408 Trillion | 1.462 Trillion | 1.261 Trillion |